Impact Takes Courage. Learn more about the Target ALS Rebecca Luker Courage Award. Know someone who is making an impact in the fight to end ALS? Submit your nomination today!
Imagine this… You feel a slight pinch in your arm one day. You don’t think much about it. Months pass and every now and then this pinch comes back. It steadily gets worse and worse, more noticeable as time goes on. It becomes bad enough that your doctor sends you to...
NEW YORK — March 5, 2021 — Today, Target ALS, a nonprofit organization founded by former NYC Deputy Mayor Dan Doctoroff — who lost his father and uncle to ALS — announced a one-night only streaming concert honoring the life of famed Broadway star Rebecca Luker....
Historians have long described the Spartans of ancient Greece as warriors—emotional and physical titans with an unbreakable spirit and a will to survive that’s nearly unparalleled. At Target ALS, we feel the same way about modern-day Spartans, the nickname for those...
If you look at the ALS patient population it’s clear that the disease doesn’t discriminate. While most patients develop ALS between the ages of 40 and 70, cases can occur at any time in life. According to the ALS Association, men are 20% more likely to be diagnosed...
Earlier this month, Target ALS and The Association for Frontotemporal Degeneration (AFTD) announced six teams who will receive a portion of $5 million in funding for projects targeting the discovery of treatments and biomarkers* for ALS and FTD. Though FTD represents...
In June, biotech giant Biogen launched a clinical trial for BIIB-100, one of the latest in their neurological disease pipeline designed to treat Amyotrophic Lateral Sclerosis (ALS)—commonly known as Lou Gehrig’s disease. Two things make this news particularly...
